Recent research suggests that cannabis could be an effective treatment for cancer and chronic pain, presenting itself as a vital alternative to opioids for post-surgical relief. However, a recently imposed funding freeze has created significant barriers to medical marijuana research. This funding instability, alongside existing federal restrictions as a Schedule I drug, introduces uncertainty and threatens ongoing studies. The National Institutes of Health and the National Institute on Drug Abuse control access to research-grade cannabis, limiting options for comprehensive investigations and posing challenges to academic freedom within the research community.
Despite increasing recognition of the medical benefits of cannabis, federal funding restrictions pose significant challenges to research, limiting both studies and access to important resources.
The recent funding freeze on medical marijuana research has introduced uncertainty, threatening ongoing projects and academic freedom, while the limited access to research materials hampers progress.
Collection
[
|
...
]